GERM vs. BATT

Last updated Jun 4, 2026

GERM (Amplify Treatments, Testing and Advancements ETF) and BATT (Amplify Lithium & Battery Technology ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while BATT is a Commodity Producers Equities fund actively managed by Amplify. GERM is passively managed, while BATT is actively managed. Over the past year, GERM returned 0.00% vs 103.56% for BATT. GERM charges 0.68%/yr vs 0.59%/yr for BATT.

Performance

GERM vs. BATT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify Lithium & Battery Technology ETF (BATT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BATT

• 1D: -1.64%
• 1M: 4.50%
• YTD: 26.16%
• 6M: 29.61%
• 1Y: 103.56%
• 3Y*: 14.36%
• 5Y*: 3.45%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. BATT - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
BATT Amplify Lithium & Battery Technology ETF	26.16%	59.70%	14.12%

GERM vs. BATT - Sectors Allocation Comparison

Sectors	GERM	BATT
Healthcare	99.3%	-
Financial Services	0.4%	0.0%
Basic Materials	-	57.0%
Communication Services	-	0.0%
Consumer Cyclical	-	18.9%
Consumer Defensive	-	-
Energy	-	-
Industrials	-	16.9%
Real Estate	-	-
Technology	-	5.6%
Utilities	-	-

Return for Risk

GERM vs. BATT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BATT

BATT Risk / Return Rank: 87
BATT Sharpe Ratio Rank: 92
BATT Sortino Ratio Rank: 81
BATT Omega Ratio Rank: 82
BATT Calmar Ratio Rank: 92
BATT Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. BATT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify Lithium & Battery Technology ETF (BATT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	GERM	BATT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	3.38	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.12	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.01	—

Drawdowns

GERM vs. BATT - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum BATT drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for GERM and BATT.

Drawdown Indicators

	GERM	BATT	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-69.38%	+69.38%
Max Drawdown (1Y) Largest decline over 1 year	0.00%	-17.03%	+17.03%
Max Drawdown (3Y) Largest decline over 3 years	—	-47.65%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-61.98%	—
Current Drawdown Current decline from peak	0.00%	-3.44%	+3.44%
Average Drawdown Average peak-to-trough decline	0.00%	-34.78%	+34.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	4.68%	-4.68%

Volatility

GERM vs. BATT - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify Lithium & Battery Technology ETF (BATT) has a volatility of 10.29%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than BATT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GERM	BATT	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	10.29%	-10.29%
Volatility (6M) Calculated over the trailing 6-month period	0.00%	24.67%	-24.67%
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	30.80%	-30.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	29.57%	-29.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	30.60%	-30.60%

GERM vs. BATT - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than BATT's 0.59% expense ratio.

Dividends

GERM vs. BATT - Dividend Comparison

GERM has not paid dividends to shareholders, while BATT's dividend yield for the trailing twelve months is around 1.47%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
BATT Amplify Lithium & Battery Technology ETF	1.47%	1.85%	3.17%	3.23%	4.14%	2.32%	0.21%	3.22%	0.89%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Which is riskier, GERM or BATT?

BATT has higher volatility (10.29%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs BATT's -69.38%.

Which ETF is better, GERM or BATT?

On 1-year performance, BATT leads with 103.56% vs 0.00% for GERM. On fees, BATT is cheaper at 0.59% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GERM or BATT?

Over the 1-year period, BATT has performed better with a 103.56% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GERM or BATT?

BATT is cheaper with a 0.59% expense ratio, compared with 0.68% for GERM.

Which ETF pays a higher dividend yield, GERM or BATT?

BATT has the higher dividend yield at 1.47%, compared with 0.00% for GERM.

What is the main difference between GERM and BATT?

GERM is categorized as Health & Biotech Equities, while BATT is Commodity Producers Equities. Their fees differ too: 0.68% for GERM and 0.59% for BATT.